Found: 119
Select item for more details and to access through your institution.
Is the Healthcare Facility Level Sufficient for Assessing the Impact of 2-Step Clostridioides difficile Testing?
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 7, p. 1050, doi. 10.1093/cid/ciad332
- By:
- Publication type:
- Article
Effect of the COVID-19 Pandemic on Rates and Epidemiology of Clostridioides difficile Infection in One VA Hospital.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 7, p. 1159, doi. 10.3390/antibiotics12071159
- By:
- Publication type:
- Article
Absence of toxin gene transfer from Clostridioides difficile strain 630Δerm to nontoxigenic C. difficile strain NTCD-M3r in filter mating experiments.
- Published in:
- PLoS ONE, 2022, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0270119
- By:
- Publication type:
- Article
Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Host Immune Responses to Clostridioides difficile : Toxins and Beyond.
- Published in:
- Frontiers in Microbiology, 2021, v. 12, p. 1, doi. 10.3389/fmicb.2021.804949
- By:
- Publication type:
- Article
Efficacy of Bezlotoxumab in Trial Participants Infected With Clostridioides difficile Strain BI Associated With Poor Outcomes.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 9, p. e2616, doi. 10.1093/cid/ciaa1035
- By:
- Publication type:
- Article
Microbiota or placebo after antimicrobial therapy for recurrent Clostridioides difficile at home: A clinical trial with novel home-based enrollment.
- Published in:
- Clinical Trials, 2021, v. 18, n. 5, p. 622, doi. 10.1177/17407745211021198
- By:
- Publication type:
- Article
A Tapered-pulsed Fidaxomicin Regimen Following Treatment in Patients With Multiple Clostridioides difficile Infection Recurrences.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 6, p. 1107, doi. 10.1093/cid/ciab233
- By:
- Publication type:
- Article
Guideline Recommendations: Optimal Timing of Publication and Resulting Rate of Adoption.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
The Relative Role of Toxins A and B in the Virulence of Clotridioides difficile.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 1, p. 96, doi. 10.3390/jcm10010096
- By:
- Publication type:
- Article
Effect of Endogenous Clostridioides difficile Toxin Antibodies on Recurrence of C. difficile Infection.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 1, p. 81, doi. 10.1093/cid/ciz809
- By:
- Publication type:
- Article
Toxin A–Predominant Pathogenic Clostridioides difficile: A Novel Clinical Phenotype.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 12, p. 2628, doi. 10.1093/cid/ciz727
- By:
- Publication type:
- Article
Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of Clostridioides (Clostridium) difficile Infection.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 6, p. 1, doi. 10.1093/ofid/ofaa157
- By:
- Publication type:
- Article
Natural Clostridioides difficile Toxin Immunization in Colonized Infants.
- Published in:
- Clinical Infectious Diseases, 2020, v. 79, n. 10, p. 2095, doi. 10.1093/cid/ciz582
- By:
- Publication type:
- Article
Unique Clindamycin-Resistant Clostridioides difficile Strain Related to Fluoroquinolone-Resistant Epidemic BI/RT027 Strain.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013-2015.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Incidence and Outcome of Clostridium difficile Infection—Beware of Strain Type and Diagnostic Tests.
- Published in:
- 2020
- By:
- Publication type:
- Opinion
Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 10, p. 1667, doi. 10.1093/cid/ciz009
- By:
- Publication type:
- Article
1496. Bezlotoxumab Administered at the End of a Suppressive Drug Regimen for Patients with Multiply Recurrent Clostridioides difficile Infection.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S545, doi. 10.1093/ofid/ofz360.1360
- By:
- Publication type:
- Article
2565. Initial and Recurrent Episodes of Clostridioides difficile: Online Education as a Tool to Improve Management Strategies.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S891, doi. 10.1093/ofid/ofz360.2243
- By:
- Publication type:
- Article
LB5. A Long-Time Coming: Final 2-year Analysis of Efficacy, Durability, and Microbiome Changes in a Controlled Open-Label Trial of Investigational Microbiota-Based Drug RBX2660 for Recurrent Clostridioides difficile Infections.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S994, doi. 10.1093/ofid/ofz415.2488
- By:
- Publication type:
- Article
Bezlotoxumab.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 4, p. 699, doi. 10.1093/cid/ciy577
- By:
- Publication type:
- Article
Treatment of Recurrent Clostridium difficile Infection.
- Published in:
- 2019
- By:
- Publication type:
- letter
Reply to Fabre et al.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 12, p. 1958, doi. 10.1093/cid/ciy475
- By:
- Publication type:
- Article
Reply to Million et al.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 11, p. 1799, doi. 10.1093/cid/ciy460
- By:
- Publication type:
- Article
Reply to Collins and Riley.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 10, p. 1640, doi. 10.1093/cid/ciy251
- By:
- Publication type:
- Article
Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660—A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 8, p. 1198, doi. 10.1093/cid/ciy259
- By:
- Publication type:
- Article
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 5, p. 649, doi. 10.1093/cid/ciy171
- By:
- Publication type:
- Article
Non-toxigenic Clostridioides (Formerly Clostridium) difficile for Prevention of C. difficile Infection: From Bench to Bedside Back to Bench and Back to Bedside.
- Published in:
- Frontiers in Microbiology, 2018, p. N.PAG, doi. 10.3389/fmicb.2018.01700
- By:
- Publication type:
- Article
Clostridium difficile Whole Genome Sequencing Reveals Limited Transmission Among Symptomatic Children: A Single-Center Analysis.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 2, p. 229, doi. 10.1093/cid/ciy060
- By:
- Publication type:
- Article
Whole-genome analysis reveals the evolution and transmission of an MDR DH/NAP11/106 Clostridium difficile clone in a paediatric hospital.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).
- Published in:
- Clinical Infectious Diseases, 2018, v. 66, n. 7, p. e1, doi. 10.1093/cid/cix1085
- By:
- Publication type:
- Article
Vancomycin Taper and Pulse Regimen With Careful Follow-up for Patients With Recurrent Clostridium difficile Infection.
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 8, p. 1396, doi. 10.1093/cid/cix529
- By:
- Publication type:
- Article
Fecal Fixation: Fecal Microbiota Transplantation for Clostridium difficile Infection.
- Published in:
- 2017
- By:
- Publication type:
- Opinion
The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Whole-Genome Sequencing of Clostridium difficile: Exquisitely Sensitive but Not Yet Optimally Applied.
- Published in:
- Clinical Infectious Diseases, 2016, v. 62, n. 6, p. 753, doi. 10.1093/cid/civ1037
- By:
- Publication type:
- Article
Identification of Medicare Recipients at Highest Risk for Clostridium difficile Infection in the US by Population Attributable Risk Analysis.
- Published in:
- PLoS ONE, 2016, v. 11, n. 2, p. 1, doi. 10.1371/journal.pone.0146822
- By:
- Publication type:
- Article
Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes.
- Published in:
- Open Forum Infectious Diseases, 2016, v. 3, n. 1, p. 1, doi. 10.1093/ofid/ofv196
- By:
- Publication type:
- Article
Concomitant Medical Conditions and Therapies Preclude Accurate Classification of Children With Severe or Severe Complicated Clostridium difficile Infection.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2015, v. 4, n. 4, p. e139, doi. 10.1093/jpids/piu121
- By:
- Publication type:
- Article
Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Administration of Spores of Nontoxigenic Clostridium difficile Strain M3 for Prevention of Recurrent C difficile Infection.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 313, n. 17, p. 1719, doi. 10.1001/jama.2015.3725
- By:
- Publication type:
- Article
Lack of Evidence for an Unmet Need to Treat Clostridium difficile Infection in Infants Aged <2 Years: Expert Recommendations on How to Address This Issue.
- Published in:
- Clinical Infectious Diseases, 2015, v. 60, n. 6, p. 912, doi. 10.1093/cid/ciu936
- By:
- Publication type:
- Article
Novel Fidaxomicin Treatment Regimens for Patients With Multiple Clostridium difficile Infection Recurrences That Are Refractory to Standard Therapies.
- Published in:
- Open Forum Infectious Diseases, 2014, v. 1, n. 2, p. 1, doi. 10.1093/ofid/ofu069
- By:
- Publication type:
- Article
Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials.
- Published in:
- Clinical Infectious Diseases, 2014, v. 59, n. 3, p. 345
- By:
- Publication type:
- Article
NAP1 Strain Type Predicts Outcomes From Clostridium difficile Infection.
- Published in:
- Clinical Infectious Diseases, 2014, v. 58, n. 10, p. 1394, doi. 10.1093/cid/ciu125
- By:
- Publication type:
- Article
Spore Formation and Toxin Production in <i>Clostridium difficile</i> Biofilms.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0087757
- By:
- Publication type:
- Article
Effect of Nucleic Acid Amplification Testing on Population-Based Incidence Rates of Clostridium difficile Infection.
- Published in:
- Clinical Infectious Diseases, 2013, v. 57, n. 9, p. 1304
- By:
- Publication type:
- Article
Surface-Layer Protein A (SlpA) Is a Major Contributor to Host-Cell Adherence of <i>Clostridium difficile</i>.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0078404
- By:
- Publication type:
- Article
A Simulation-Based Assessment of Strategies to Control <i>Clostridium Difficile</i> Transmission and Infection.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0080671
- By:
- Publication type:
- Article
Epidemiology of Community-Associated Clostridium difficile Infection, 2009 Through 2011.
- Published in:
- JAMA Internal Medicine, 2013, v. 173, n. 14, p. 1359, doi. 10.1001/jamainternmed.2013.7056
- By:
- Publication type:
- Article